Annual Drug Patent Expirations for RIVIVE
Rivive is a drug marketed by Harm Reduction Therp and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has forty-five patent family members in thirty-six countries.
The generic ingredient in RIVIVE is naloxone hydrochloride. One supplier is listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com